144 related articles for article (PubMed ID: 36175634)
1. Characterization of Human Parainfluenza Virus Receptor Using Terminal Sialic Acid Linkage-Modified Cells.
Fukushima K; Takahashi T; Suzuki T
Methods Mol Biol; 2022; 2556():169-178. PubMed ID: 36175634
[TBL] [Abstract][Full Text] [Related]
2. Terminal sialic acid linkages determine different cell infectivities of human parainfluenza virus type 1 and type 3.
Fukushima K; Takahashi T; Ito S; Takaguchi M; Takano M; Kurebayashi Y; Oishi K; Minami A; Kato T; Park EY; Nishimura H; Takimoto T; Suzuki T
Virology; 2014 Sep; 464-465():424-431. PubMed ID: 25146600
[TBL] [Abstract][Full Text] [Related]
3. Amino acid substitutions contributing to α2,6-sialic acid linkage binding specificity of human parainfluenza virus type 3 hemagglutinin-neuraminidase.
Fukushima K; Takahashi T; Ueyama H; Takaguchi M; Ito S; Oishi K; Minami A; Ishitsubo E; Tokiwa H; Takimoto T; Suzuki T
FEBS Lett; 2015 May; 589(11):1278-82. PubMed ID: 25871520
[TBL] [Abstract][Full Text] [Related]
4. α2,3-Linked Sialic Acids Are the Potential Attachment Receptor for Shaan Virus Infection in MARC-145 Cells.
Jang SS; Noh JY; Kim MC; Lim HA; Song MS; Kim HK
Microbiol Spectr; 2022 Aug; 10(4):e0125622. PubMed ID: 35924912
[TBL] [Abstract][Full Text] [Related]
5. The Sialic Acid Binding Activity of Human Parainfluenza Virus 3 and Mumps Virus Glycoproteins Enhances the Adherence of Group B Streptococci to HEp-2 Cells.
Tong J; Fu Y; Meng F; Krüger N; Valentin-Weigand P; Herrler G
Front Cell Infect Microbiol; 2018; 8():280. PubMed ID: 30175075
[TBL] [Abstract][Full Text] [Related]
6. Receptor specificities of human respiroviruses.
Suzuki T; Portner A; Scroggs RA; Uchikawa M; Koyama N; Matsuo K; Suzuki Y; Takimoto T
J Virol; 2001 May; 75(10):4604-13. PubMed ID: 11312330
[TBL] [Abstract][Full Text] [Related]
7. Human parainfluenza viruses hPIV1 and hPIV3 bind oligosaccharides with alpha2-3-linked sialic acids that are distinct from those bound by H5 avian influenza virus hemagglutinin.
Amonsen M; Smith DF; Cummings RD; Air GM
J Virol; 2007 Aug; 81(15):8341-5. PubMed ID: 17522226
[TBL] [Abstract][Full Text] [Related]
8. Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein.
Alymova IV; Portner A; Mishin VP; McCullers JA; Freiden P; Taylor GL
Glycobiology; 2012 Feb; 22(2):174-80. PubMed ID: 21846691
[TBL] [Abstract][Full Text] [Related]
9. Role of Neuraminidase in Influenza A(H7N9) Virus Receptor Binding.
Benton DJ; Wharton SA; Martin SR; McCauley JW
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356530
[TBL] [Abstract][Full Text] [Related]
10. New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase.
Chibanga VP; Dirr L; Guillon P; El-Deeb IM; Bailly B; Thomson RJ; von Itzstein M
Antiviral Res; 2019 Jul; 167():89-97. PubMed ID: 30951732
[TBL] [Abstract][Full Text] [Related]
11. Receptor binding specificity of recent human H3N2 influenza viruses.
Kumari K; Gulati S; Smith DF; Gulati U; Cummings RD; Air GM
Virol J; 2007 May; 4():42. PubMed ID: 17490484
[TBL] [Abstract][Full Text] [Related]
12. Human trachea primary epithelial cells express both sialyl(alpha2-3)Gal receptor for human parainfluenza virus type 1 and avian influenza viruses, and sialyl(alpha2-6)Gal receptor for human influenza viruses.
Kogure T; Suzuki T; Takahashi T; Miyamoto D; Hidari KI; Guo CT; Ito T; Kawaoka Y; Suzuki Y
Glycoconj J; 2006 Feb; 23(1-2):101-6. PubMed ID: 16575527
[TBL] [Abstract][Full Text] [Related]
13. The evolution of galactose alpha2,3-sialyltransferase: Ciona intestinalis ST3GAL I/II and Takifugu rubripes ST3GAL II sialylate Galbeta1,3GalNAc structures on glycoproteins but not glycolipids.
Lehmann F; Kelm S; Dietz F; von Itzstein M; Tiralongo J
Glycoconj J; 2008 May; 25(4):323-34. PubMed ID: 17973185
[TBL] [Abstract][Full Text] [Related]
14. Enterovirus 70 binds to different glycoconjugates containing alpha2,3-linked sialic acid on different cell lines.
Nokhbeh MR; Hazra S; Alexander DA; Khan A; McAllister M; Suuronen EJ; Griffith M; Dimock K
J Virol; 2005 Jun; 79(11):7087-94. PubMed ID: 15890948
[TBL] [Abstract][Full Text] [Related]
15. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.
Levin Perlman S; Jordan M; Brossmer R; Greengard O; Moscona A
Virology; 1999 Dec; 265(1):57-65. PubMed ID: 10603317
[TBL] [Abstract][Full Text] [Related]
16. Solid-Phase Binding Assay for Ganglioside Binding of Human Respiroviruses.
Suzuki T
Methods Mol Biol; 2022; 2556():179-186. PubMed ID: 36175635
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of amino acids at stalk/head interface of human parainfluenza virus type 3 hemagglutinin-neuraminidase protein in the membrane fusion process.
Jiang J; Wen H; Chi M; Liu Y; Liu J; Cao Z; Zhao L; Song Y; Liu N; Chi L; Wang Z
Virus Genes; 2018 Jun; 54(3):333-342. PubMed ID: 29516315
[TBL] [Abstract][Full Text] [Related]
18. α2-3- and α2-6- N-linked sialic acids allow efficient interaction of Newcastle Disease Virus with target cells.
Sánchez-Felipe L; Villar E; Muñoz-Barroso I
Glycoconj J; 2012 Oct; 29(7):539-49. PubMed ID: 22869099
[TBL] [Abstract][Full Text] [Related]
19. [Role of Glycoconjugates and Mammalian Sialidases Involved in Viral Infection and Neural Function].
Suzuki T
Yakugaku Zasshi; 2022; 142(4):381-388. PubMed ID: 35370194
[TBL] [Abstract][Full Text] [Related]
20. A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity.
Murrell MT; Porotto M; Greengard O; Poltoratskaia N; Moscona A
J Virol; 2001 Jul; 75(14):6310-20. PubMed ID: 11413297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
